Article
PTPRS Regulates Colorectal Cancer RAS Pathway Activity by Inactivating Erk and Preventing Its Nuclear Translocation.
Scientific reports - 18 Jun 2018
Davis Thomas B, Yang Mingli, Schell Michael J, Wang Heiman, Ma Le, Pledger W Jack, Yeatman Timothy J
Abstract excerpt
Colorectal cancer (CRC) growth and progression is frequently driven by RAS pathway activation through upstream growth factor receptor activation or through mutational activation of KRAS or BRAF. Here we describe an additional mechanism by which the RAS pathway may be modulated in CRC. PTPRS, a receptor-type protein tyrosine phosphatase, appears to regulate RAS pathway activation through ERK. PTPRS modulates ERK...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
